FcRn: the neonatal Fc receptor comes of age - PubMed (original) (raw)
Review
doi: 10.1038/nri2155. Epub 2007 Aug 17.
Affiliations
- PMID: 17703228
- DOI: 10.1038/nri2155
Review
FcRn: the neonatal Fc receptor comes of age
Derry C Roopenian et al. Nat Rev Immunol. 2007 Sep.
Abstract
The neonatal Fc receptor for IgG (FcRn) has been well characterized in the transfer of passive humoral immunity from a mother to her fetus. In addition, throughout life, FcRn protects IgG from degradation, thereby explaining the long half-life of this class of antibody in the serum. In recent years, it has become clear that FcRn is expressed in various sites in adults, where its potential function is now beginning to emerge. In addition, recent studies have examined the interaction between FcRn and the Fc portion of IgG with the aim of either improving the serum half-life of therapeutic monoclonal antibodies or reducing the half-life of pathogenic antibodies. This Review summarizes these two areas of FcRn biology.
Similar articles
- A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
Andersen JT, Justesen S, Berntzen G, Michaelsen TE, Lauvrak V, Fleckenstein B, Buus S, Sandlie I. Andersen JT, et al. J Immunol Methods. 2008 Feb 29;331(1-2):39-49. doi: 10.1016/j.jim.2007.11.003. Epub 2007 Dec 10. J Immunol Methods. 2008. PMID: 18155020 - Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
Wang Y, Tian Z, Thirumalai D, Zhang X. Wang Y, et al. J Drug Target. 2014 May;22(4):269-78. doi: 10.3109/1061186X.2013.875030. Epub 2014 Jan 9. J Drug Target. 2014. PMID: 24404896 Review. - The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.
Andersen JT, Dee Qian J, Sandlie I. Andersen JT, et al. Eur J Immunol. 2006 Nov;36(11):3044-51. doi: 10.1002/eji.200636556. Eur J Immunol. 2006. PMID: 17048273 - The multiple facets of FcRn in immunity.
Stapleton NM, Einarsdóttir HK, Stemerding AM, Vidarsson G. Stapleton NM, et al. Immunol Rev. 2015 Nov;268(1):253-68. doi: 10.1111/imr.12331. Immunol Rev. 2015. PMID: 26497526 Review.
Cited by
- Exploring the Interplay Between Radioimmunoconjugates and Fcγ Receptors in Genetically Engineered Mouse Models of Cancer.
Rodriguez C, Sarrett SM, Sebastiano J, Delaney S, McGlone SA, Hosny MM, Thau S, Bournazos S, Zeglis BM. Rodriguez C, et al. ACS Pharmacol Transl Sci. 2024 Oct 17;7(11):3452-3461. doi: 10.1021/acsptsci.4c00275. eCollection 2024 Nov 8. ACS Pharmacol Transl Sci. 2024. PMID: 39539260 - The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts.
Galan R, Pembrey L, Bustamante M, Aguilar R, Mason D, Vidal M, Bañuls M, Roumeliotaki T, Delgado-Saborit JM, Marin N, Vrijheid M, Bempi V, Moncunill G, Dobaño C, Kogevinas M, Karachaliou M. Galan R, et al. BMC Pregnancy Childbirth. 2024 Nov 12;24(1):745. doi: 10.1186/s12884-024-06901-5. BMC Pregnancy Childbirth. 2024. PMID: 39533217 Free PMC article. - Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies.
Choi SM, Lee JH, Ko S, Hong SS, Jin HE. Choi SM, et al. Biomol Ther (Seoul). 2024 Nov 1;32(6):708-722. doi: 10.4062/biomolther.2024.146. Epub 2024 Oct 25. Biomol Ther (Seoul). 2024. PMID: 39448393 Free PMC article. Review. - Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.
Rodriguez SMB, Tataranu LG, Kamel A, Turliuc S, Rizea RE, Dricu A. Rodriguez SMB, et al. Int J Mol Sci. 2024 Oct 7;25(19):10765. doi: 10.3390/ijms251910765. Int J Mol Sci. 2024. PMID: 39409094 Free PMC article. Review. - Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives.
Kim HJ, Werth VP. Kim HJ, et al. Ann Dermatol. 2024 Oct;36(5):257-265. doi: 10.5021/ad.24.022. Ann Dermatol. 2024. PMID: 39343752 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases